Cargando…

A234 IN VITRO GUT MICROBIOME AND METABOLITE RESPONSES TO RESISTANT STARCH ARE INDIVIDUALIZED

BACKGROUND: Gut microbes degrade and ferment resistant starch (RS) into metabolites that help maintain gut homeostasis. Clinical trials have evaluated RS for various health conditions, but individuals respond to RS with profound variability. The reason for this variability is unclear. AIMS: Using in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dobranowski, P, Qin, H, Walker, K, Butcher, J, Gowing, A, Singleton, R, Mayne, J, Mack, D R, Figeys, D, Stintzi, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Poster of Distinction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859390/ http://dx.doi.org/10.1093/jcag/gwab049.233

Ejemplares similares

A233 CHARACTERIZATION OF THE DUODENAL MICROBIOME IN PEDIATRIC CELIAC AND INFLAMMATORY BOWEL DISEASE PATIENTS
por: Manoogian, J, et al.
Publicado: (2022)

Resistant starch, microbiome, and precision modulation
por: Dobranowski, Peter A., et al.
Publicado: (2021)

A functional ecological network based on metaproteomics responses of individual gut microbiomes to resistant starches
por: Li, Leyuan, et al.
Publicado: (2020)

A238 ALTERED GUT MICROBIOME COMPOSITION AND FUNCTION ARE ASSOCIATED WITH GUT BARRIER DYSFUNCTION IN HEALTHY RELATIVES OF CROHN’S DISEASE PATIENTS
por: Leibovitzh, H, et al.
Publicado: (2022)

A46 ENTEROBACTERIACEAE ENRICHMENT IN THE GUT MICROBIOME OF CRITICALLY ILL PATIENTS PROMOTES IMMUNE DYSFUNCTION AND SUSCEPTIBILITY TO NOSOCOMIAL INFECTIONS
por: Schlechte, J M, et al.
Publicado: (2023)

Examining the Effects of an Anti-Salmonella Bacteriophage Preparation, BAFASAL(®), on Ex-Vivo Human Gut Microbiome Composition and Function Using a Multi-Omics Approach
por: Mayne, Janice, et al.
Publicado: (2021)

A231 COLORECTAL CANCER PROVINCIAL SCREENING OPTIMIZATION USING GUT MICROBIOME AS BIOMARKER
por: Laforest-Lapointe, I
Publicado: (2022)

Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes
por: Li, Leyuan, et al.
Publicado: (2020)

A236 ASSOCIATION OF STOOL METABOLOMIC PROFILE AND MICROBIOME COMPOSITION RISK SCORE WITH FUTURE ONSET OF CROHN’S DISEASE
por: Lee, S, et al.
Publicado: (2022)

Revealing proteome-level functional redundancy in the human gut microbiome using ultra-deep metaproteomics
por: Li, Leyuan, et al.
Publicado: (2023)

A39 HEALTHY FIRST-DEGREE RELATIVES FROM MULTIPLEX FAMILIES VERSUS SIMPLEX HARBOR A HIGHER RISK OF DEVELOPING CROHN'S DISEASE AND ARE ASSOCIATED WITH SUBCLINICAL INFLAMMATION AND ALTERED MICROBIOME COMPOSITION
por: Olivera, P, et al.
Publicado: (2023)

A157 DEFINITIONS OF MEDITERRANEAN DIET INCONSISTENTLY ASSOCIATE WITH MARKERS OF GUT BARRIER FUNCTION OR SUBCLINICAL INFLAMMATION IN A POPULATION-BASED COHORT
por: Neustaeter, A, et al.
Publicado: (2022)

An in vitro model maintaining taxon-specific functional activities of the gut microbiome
por: Li, Leyuan, et al.
Publicado: (2019)

Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn’s disease
por: Zhang, Xu, et al.
Publicado: (2020)

Comprehensive Assessment of Functional Effects of Commonly Used Sugar Substitute Sweeteners on Ex Vivo Human Gut Microbiome
por: Sun, Zhongzhi, et al.
Publicado: (2022)

RapidAIM: a culture- and metaproteomics-based Rapid Assay of Individual Microbiome responses to drugs
por: Li, Leyuan, et al.
Publicado: (2020)

Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease
por: Zhang, Xu, et al.
Publicado: (2018)

Evaluating live microbiota biobanking using an ex vivo microbiome assay and metaproteomics
por: Zhang, Xu, et al.
Publicado: (2022)

Advancing functional and translational microbiome research using meta-omics approaches
por: Zhang, Xu, et al.
Publicado: (2019)

A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
por: El-Matary, W, et al.
Publicado: (2022)

A46 BIOGEOGRAPHIC VARIATION AND FUNCTIONAL PATHWAYS OF THE GUT MICROBIOTA IN CELIAC DISEASE
por: Libertucci, J, et al.
Publicado: (2022)

A51 ROLE OF GUT MICROBIOTA IN THE EPISODIC NATURE OF SYMPTOMS IN IRRITABLE BOWEL SYNDROME
por: Mohan, V, et al.
Publicado: (2022)

A47 THE GUT MICROBIOTA INFLUENCES COLONIC HEALING AFTER SURGERY IN PATIENTS UNDERGOING BOWEL RESECTION FOR COLORECTAL CANCER
por: Hajjar, R, et al.
Publicado: (2023)

A248 THE ROLE OF DIETARY TRYPTOPHAN IN INDOLE AND KYNURENINE PRODUCTION AND IMMUNE MODULATION IN HEALTHY INDIVIDUALS
por: Rueda, G H, et al.
Publicado: (2022)

A77 IMPLEMENTATION OF GUT LINK-IBS; RESULTS OF A SEMI-STRUCTURED INTERVIEW OF PRIMARY CARE PROVIDERS
por: Sharma, S, et al.
Publicado: (2022)

A40 GUT MICROBIOTA PROMOTES NUTRIENT AVAILABLITY AND PATHOGENESIS OF AN ATTACHING/ EFFACING BACTERIAL PATHOGEN
por: Liang, Q, et al.
Publicado: (2023)

A97 DEVELOPMENT OF PREDICTION MODELS FOR THE TRIAGING OF REFERRALS OF INDIVIDUALS WITH SUSPECTED INFLAMMATORY BOWEL DISEASE TO IMPROVE PROMPT ACCESS TO CARE
por: St-Pierre, J, et al.
Publicado: (2022)

A55 INTERLEUKIN-10 ELICITS CYTOPROTECTION VIA MITOCHONDRIAL SIGNAL TRANSDUCER AND ACTIVATORS OF TRANSCRIPTION 3 (MTSTAT3) TO PREVENT BACTERIAL PATHOBIONT EVOKED MITOCHONDRIAL FRAGMENTATION IN GUT EPITHELIA
por: NavaneethaKrishnan, S, et al.
Publicado: (2022)

A23 INTESTINAL STEM CELL REGULATION BY THE BACTERIAL METABOLITE ADP-HEPTOSE VIA ACTIVATION OF THE ALPK1-TIFA SIGNALLING PATHWAY
por: Goyal, S, et al.
Publicado: (2023)

A235 ILEAL MICROBIOME ALPHA DIVERSITY REMAINS LOWER IN ENDOSCOPICALLY AND HISTOLOGICALLY INACTIVE CROHN’S DISEASE COMPARED TO ULCERATIVE COLITIS OR HEALTHY CONTROLS
por: Olivera Sendra, P A, et al.
Publicado: (2022)

A199 UTILIZATION OF MUCUS-DERIVED O-GLYCAN SUGARS BY THE PATHOGEN C. RODENTIUM FACILITATE ITS COLONIZATION OF THE MURINE GUT
por: Mslati, M, et al.
Publicado: (2022)

A85 THE CLINICAL IMPACT OF COVID-19 DELAYS ON PLASTIC BILIARY STENT REMOVAL IN NOVA SCOTIA
por: Lim, D R, et al.
Publicado: (2021)

A52 GUT-INNERVATING TRPV1+ NEURONS DRIVE CHRONIC VISCERAL PAIN VIA MICROGLIAL P2Y12 RECEPTOR
por: Defaye, M, et al.
Publicado: (2022)

A212 LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS (PSC): EXPERIENCE FROM THE LAST THREE DECADES
por: Zhu, J, et al.
Publicado: (2022)

A25 CRITICAL APPRAISAL OF GI ENDOSCOPY CLINICAL PRACTICE GUIDELINES DURING THE COVID-19 PANDEMIC
por: Tham, D, et al.
Publicado: (2022)

A122 OUTCOMES OF COLD SNARE POLYPECTOMY FOR POLYPS GREATER THAN 20 MM: DATA FROM AN ACADEMIC CENTER
por: Johar, J, et al.
Publicado: (2022)

MetaPro-IQ: a universal metaproteomic approach to studying human and mouse gut microbiota
por: Zhang, Xu, et al.
Publicado: (2016)

A107 WHAT SIZE CUT-OFF LEVEL SHOULD BE USED TO IMPLEMENT OPTICAL POLYP DIAGNOSIS?
por: Taghiakbari, M, et al.
Publicado: (2022)

Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol
por: Castillo, Gisell, et al.
Publicado: (2021)

A224 COVID-19 INFECTION IN LIVER TRANSPLANT RECIPIENTS: CLINICAL FEATURES, HOSPITALIZATION, AND MORTALITY FROM A CANADIAN MULTICENTRE COHORT
por: Smith, M K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ik42bov581gqtfgmskuqaeal9